Stichting Hemato-oncologie Voor Volwassenen Nederland

This study is testing whether a drug called tislelizumab, when given with standard chemotherapy, can help control Hodgkin lymphoma that has come back or hasn't responded to initial treatment. The goal is to see if this approach works as well as the current intensive standard trea…

This study is testing whether the drug zanubrutinib can help control cold agglutinin disease, a rare condition where the immune system attacks red blood cells, causing anemia and painful reactions to cold. The trial will enroll about 25 adults who have not responded well to other…

This study tests whether adding the immunotherapy drug atezolizumab after standard chemotherapy can help prevent cancer from returning in patients with high-risk diffuse large B-cell lymphoma. The trial enrolled 109 adults who had responded well to initial treatment but remain at…